SUO 2017 Prostate Cancer - Results from #35

Viewing 36-55 of 64 articles

SUO 2017: Alterations in Steroid Metabolism and AR Responsiveness

SUO 2017: The Need of CT Imaging for Staging High Risk Prostate Cancer

SUO 2017: Population-based Outcomes Of Men With A Single Negative Prostate Biopsy: Importance Of Continued Follow Up Among Older Patients

SUO 2017: The Institutional Learning Curve For Prostate MRI And MRI-US Fusion-targeted Biopsy: Improvements In Cancer Detection Over Time Based On 1400 Prostate Biopsies

SUO 2017: A Quantitative Assessment Of Residual Confounding In The Comparison Between Surgery And Radiotherapy In The Treatment Of Non-Metastatic Prostate Cancer

SUO 2017: National Trends in the Management of Patients with Positive Surgical Margin at the Time of Radical Prostatectomy

SUO 2017: Association Between Androgen-Deprivation Therapy And Non-Prostate Cancer Mortality Among Men With Non-Metastatic Prostate Cancer

SUO 2017: Does MPMRI Perform Differently in Men Undergoing Targeted Biopsy for Evaluation Of Prostate Cancer Versus those on Active Surveillance?

SUO 2017: Prostate MRI Interpretation Varies Substantially Across Radiologists

SUO 2017: Analysis of External Beam Radiation Therapy, Low-Dose Rate and Combined External Beam with Brachytherapy in Prostate Cancer

SUO 2017: Predictors Of Early Disease Specific Mortality Among Patients With Prostate Adenocarcinoma Bone Metastasis At Diagnosis

SUO 2017: Survival Outcomes For African-American Versus Matched Caucasian Patients With mCRPC Treated With Sipuleucel-T

SUO 2017: Prostate Cancer Incidence, Treatment Trends, and Survival Among American Indians and Alaskan Natives in The U.S

SUO 2017: Metastasis-Free Survival Endpoint

SUO 2017: Progression-Free Survival (PSA) Endpoint

SUO 2017: Optimal Timing of Adjuvant and Salvage Radiation Following Radical Prostatectomy

SUO 2017: Using Genomic Biomarkers to Select Patients for Postoperative Therapies for Prostate Cancer

SUO 2017: Genomics and Molecular Testing after Radical Prostatectomy

SUO 2017: Trials, Trends, and Models: Synthesizing the Evidence on Prostate Cancer Screening

SUO 2017: From Biopsy, AS vs Rx: Stratifying Risk in Localized PCa

1
2
3
4